| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.02. | Inspira Technologies: Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency | 75 | GlobeNewswire (Europe) | Ra'anana, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira Technologies" or the "Company"), a pioneer in innovative life-support and... ► Artikel lesen | |
| 25.02. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.02. | Inspira Technologies: Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State | 1 | GlobeNewswire (USA) | ||
| 18.02. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.02. | Inspira Technologies: Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks | 467 | GlobeNewswire (Europe) | RA'ANANA, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira Technologies," "Inspira," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 12.02. | Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement | 123 | GlobeNewswire (Europe) | RA'ANANA, Israel, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) ("Inspira Technologies" or the "Company"), a pioneer in innovative life-support and diagnostic... ► Artikel lesen | |
| 06.02. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 03.02. | Inspira Technologies Validates Next-Gen Standalone HYLA Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market | 4 | GlobeNewswire (USA) | ||
| 29.01. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 21.01. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.01. | Inspira Technologies: Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders | 1 | GlobeNewswire (USA) | ||
| 08.01. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 08.01. | Inspira Technologies: Aktie steigt nach Bekanntgabe von Expansionsplänen im Bereich Flüssigbiopsie | 3 | Investing.com Deutsch | ||
| 08.01. | Inspira Technologies: Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion | 1 | GlobeNewswire (USA) | ||
| 06.01. | Inspira Technologies OXY B.H.N. Ltd - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 05.01. | Inspira Technologies: Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation | 1 | GlobeNewswire (USA) | ||
| 31.12.25 | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.12.25 | Inspira Technologies reaffirms $49.5 million in purchase orders | 3 | Investing.com | ||
| 23.12.25 | Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones | 363 | GlobeNewswire (Europe) | RA'ANANA, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies... ► Artikel lesen | |
| 23.12.25 | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,200 | 0,00 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
06.03.2026 / 10:45... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,310 | 0,00 % | Siemens Healthineers: Drei Belastungen | Am 7. Mai wird Siemens Healthineers Zahlen zum zweiten Quartal publizieren. Die Analysten der DZ Bank glauben, dass diese schwach ausfallen werden. Drei Aspekte belasten derzeit die Daten: Die US-Zölle... ► Artikel lesen | |
| UNITEDHEALTH | 246,60 | -0,04 % | Dividendenbekanntmachungen (09.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANSIX INC US00773T1016 0,16 USD 0,1377 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2496 EUR ALPHABET INC CDR CA02080K1049 0... ► Artikel lesen | |
| MEDTRONIC | 77,80 | +1,09 % | Medtronic To Buy Scientia Vascular | LONDON (dpa-AFX) - Medtronic PLC (MDT, 2M6.DE), an Irish healthcare technology company, said on Tuesday that it has inked a deal to acquire Scientia Vascular. The acquisition is valued at $550... ► Artikel lesen | |
| INTUITIVE SURGICAL | 424,15 | -0,39 % | $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today | ||
| THERMO FISHER | 428,35 | +0,01 % | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| HIMS & HERS HEALTH | 24,000 | +4,21 % | Opening Bell: Novo Nordisk, Hims & Hers, Nvidia, Oracle, Marvell, Interconti. Exchange, RTX & Co. | Die US-Börsen haben den Wochenausklang mit deutlichen Verlusten beendet. Der Dow Jones fiel 0,95 Prozent, während der Nasdaq Composite 1,59 Prozent verlor. Die Handelswoche stand an der Wall Street... ► Artikel lesen | |
| OTTOBOCK | 53,85 | 0,00 % | OTTOBOCK SE & CO KGAA - Stabilität als Fundament | ||
| CARDINAL HEALTH | 186,25 | +0,08 % | Leerink Partners bekräftigt Outperform-Rating für Cardinal Health | ||
| RESMED | 208,10 | +0,29 % | Hedge Fund and Insider Trading News: Bill Ackman, Stanley Druckenmiller, Ken Griffin, Caxton Associates, Braidwell LP, Rokos Capital Management, ResMed Inc (RMD), Accel Entertainment Inc (ACEL), and More | ||
| MCKESSON | 809,20 | +0,25 % | 221% Kursgewinn - und jetzt kommt der größte Trigger: FDA-Entscheidung steht bevor | ||
| SOLVENTUM | 58,00 | -0,68 % | Solventum Corporation Announces Increase In Q4 Income | WASHINGTON (dpa-AFX) - Solventum Corporation (SOLV) reported a profit for its fourth quarter that Increases, from last yearThe company's bottom line totaled $63 million, or $0.36 per share.... ► Artikel lesen | |
| ZIMMER BIOMET | 78,74 | -2,79 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board... ► Artikel lesen | |
| CENTENE | 30,900 | -0,18 % | ROUNDUP/Aktien New York: Moderate Gewinne - Iran-Vorsicht bleibt | NEW YORK (dpa-AFX) - An den US-Börsen habe die Anleger nach der Vortageserholung wieder vorsichtig agiert. Die wichtigsten Indizes pendelten am Dienstag kurz nach dem Handelsstart um ihre Schlusskurse... ► Artikel lesen | |
| INSULET | 205,20 | -0,58 % | Insulet Corporation: Insulet to Present EVOLUTION 2 Results on Omnipod Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) | Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also... ► Artikel lesen |